Use of Systemic Medications for Treating Adult Atopic Dermatitis in France: Results of a Practice Survey.
Anne-Claire FougerousseCaroline JacobzoneLaure Mery-BossardZiad ReguiaiCatherine DroitcourtCharles TaïebFrançois Maccarinull nullPublished in: Clinical, cosmetic and investigational dermatology (2021)
Systemic treatments for AD are used by half of dermatologists, although cyclosporine and dupilumab must be initiated in hospitals in France. Methotrexate is more frequently used than cyclosporine, although it is not approved for this indication in France. A vast majority of dermatologists do not perform any evaluation scoring before initiating systemic treatment for adult AD.